Nevro (NYSE: NVRO)
Nevro Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nevro Company Info
Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
News & Analysis
Why Nevro Stock Lagged the Market on Thursday
Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.
Why Shares of Nevro Are Down Wednesday
The medical device maker saw increased revenue, but earnings lagged estimates.
Why Nevro Stock Is Tanking Today
The moody market is punishing this medical device stock yet again today.
Why Nevro Is Falling So Hard Today
A narrower-than-expected loss was about the only bright spot in the company's second-quarter results.
These Were the 10 Best Healthcare Stocks of 2019
Helping people stricken with illness can be richly rewarding in more ways than one.
3 Under-the-Radar Healthcare Stocks to Buy in December
These niche businesses are growing by leaps and bounds.
Here's Why Nevro Stock Bounded Higher on Thursday
A third-quarter earnings report that beat expectations lifted spirits and the medical-device stock.
Why Chesapeake Energy, Nutanix, and Nevro Jumped Today
Favorable market moves and optimism about the future lifted these stocks.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.